Meanwhile, silencing of Fatp2 and Fatp5 can improve NAFLD induced by HFD (Doege et al., 2006, 2008; Falcon et al., 2010). Here, SLC27A2 is linked to metabolic dysfunction-associated steatotic liver disease.